Carlyle and Piramal Pharma Sign Agreement on a 20% Strategic Growth Investment
Carlyle and Piramal Pharma Sign Agreement on a 20% Strategic Growth Investment
Piramal Group Commits INR 25 Crores to COVID-19 Relief Effort
Piramal Realty Makes a Foray into Value Housing Segment
PEL raises funds of ~INR 14,500 Crores in FY2020
Piramal Divests its DRG Business for US$950 Million
Piramal Swasthya and The Rockefeller Foundation Announce Partnership to Accelerate India’s Public Health Transformation
Piramal Foundation and Gates Foundation Partner to Setup a Tribal Health Collaborative for India
Piramal Swasthya has been recognized by USAID with the ‘Inclusive Health Access Award’ for its High Impact Healthcare Platform
IndiaRF Announces US$144 Million Investment in Panacea Biotec Ltd.
Supreme Court Exempts Saridon from the List of Banned FDCs
Piramal Enterprises Limited signed a Memorandum of Understanding with CPPIB
IndiaRF Announces US$156 Million Investment in Archean Group’s Marine Chemicals Business | 2018
NITI Aayog Partners with Piramal Foundation
Piramal Realty launches Piramal Mahalaxmi, its Flagship Project in South Mumbai
Piramal Finance Limited Forays into the Hospitality Sector
Piramal Enterprises Completes the Acquisition of a Portfolio of Drugs for Spasticity and Pain Management from Mallinckrodt LLC.
Piramal Realty marks exclusive pre-Launch of Piramal Revanta
Piramal Enterprises Limited and Ivanhoé Cambridge announce Partnership to Invest in Residential Developments in India
Piramal Enterprises Limited announces its plan to enter Housing Finance
Piramal Fund Management launches an Innovative Flexi Lease Rental Discounting (LRD) for Commercial Assets.
Piramal Enterprises Critical Care Division expands its product portfolio; enters into an agreement to acquire Janssen's Injectable Anaesthesia and Pain Management products
Piramal Enterprises Limited and Bain Capital Credit to pursue distressed debt investing in India
Piramal Enterprises enters into an agreement to acquire Ash Stevens Inc., a US based Contract and Drug Manufacturing Orgnisation (CDMO) for High Potency APIs (HPAPIs)
Piramal Realty forays into commercial real estate with the launch of Piramal Agastya Corporate Park in Kurla, Mumbai
Piramal Enterprises enters an agreement to acquire four brands from Pfizer Limited for its Consumer Products Business
Piramal Realty launches its signature project, Piramal Aranya in Byculla, Mumbai
Piramal Enterprises announces the sale of its Canada-based cartilage repair product, BST-CarGel® to Smith & Nephew
Piramal Enterprises acquires five brands from Organon India Pvt. Ltd. (OIPL) and MSD BV for its Consumer Products Business.
Piramal Enterprises acquires the Baby Care brand – Little’s for the Consumer Products Business
Piramal Realty launches a new community for natural and holistic living at Balkum, Thane, Mumbai: Piramal Vaikunth
Piramal Realty secures $150 million (INR 900 crore) from Goldman Sachs
Warburg Pincus to invest INR 1800cr in Piramal Realty
DRG has acquired Healthcare Business Insights (HBI), a trusted provider of best Practice research, training and services to more than 1,400 hospitals across the U.S.
Piramal Enterprises Ltd. acquires Kentucky based Specialty Pharmaceutical CDMO, Coldstream Laboratories Inc.
Decision Resources Group acquired Relay Technology Management. The acquisition adds new products and significant technological capabilities.
Canada Pension Plan Investment Board (CPPIB) and Piramal Enterprises Limited announce a US$500 million Strategic Alliance for Residential Development Debt Financing in India; appoint Piramal Fund Management (at the time known as Indiareit) as advisor
Piramal Enterprises Limited agrees to acquire an effective 20% equity stake in Shriram Capital Limited, a financial services company, for an aggregate consideration of INR 20.14 Billion
Piramal Enterprises Limited acquires 9.99% equity stake in Shriram City Union Finance Limited
APG Asset Management, the Dutch pension fund asset manager and Piramal Enterprises Limited announce a strategic alliance for investing in rupee denominated mezzanine instruments issued by infrastructure companies in India with a target investment of US$1 billion, over the next 3 years
Piramal Enterprises Ltd. consumer products' division acquires the brand CALADRYL® in India.
Piramal Water (Sarvajal) honoured with 'Enabling Technology Award of the Year 2013' by Frost & Sullivan
Imaging division's lead radiopharmaceutical, Florbetaben, accepted for review by the US FDA and EMA for the visual detection of Beta-Amyloid in Alzheimer's disease
Piramal Enterprises Limited acquires Molecular Imaging Development portfolio of Bayer Pharma
Piramal Healthcare Limited is renamed to Piramal Enterprises Limited.
Piramal Realty, a privately owned real estate entity, was formed
Piramal Enterprises acquires health care information management firm, Decision Resources Group, USA for US$635 million
Piramal Enterprises starts a Non-Banking Financial Company (NBFC) focused on lending to real estate, education and hospitals
BST-CarGel, our innovative bio-orthopedic product for cartilage repair, receives European CE mark approval
Decision Resources Group acquires Abacus International, a UK based global market access solutions company for many of the world’s leading health care companies
Piramal Realty wins the auction of the landmark Hindustan Unilever training centre at Worli Sea Face, Mumbai
Piramal's Pharma Solutions manufacturing site at Grangemouth, Scotland becomes the world’s first contract supplier at commercial scale for ADCs.
Fortune 500 ranks Piramal Healthcare in the top-50 largest corporations across India
Piramal Healthcare acquires Indiareit, a real estate focused investment trust with AUM of US$760 Million
UN Conference on Trade and Development’s World Investment Report 2011 ranks Piramal Healthcare as No. 5 in the top 10 pharmaceutical contract manufacturers worldwide
Piramal Healthcare acquires 11% of Vodafone India
Piramal Realty acquires Mafatlal Mills in Byculla, Mumbai
Oxygen Bio-research is acquired by Piramal Enterprises and is part of the Pharmaceutical Solutions division
Bharat Serum and Vaccines Ltd – Anaesthetics business buyout by Piramal Enterprises Ltd.
Acquisition of iPill, an oral contraceptive brand, from Cipla.
Piramal sells the diagnostics division to Super Religare Laboratories Ltd
Biosyntech, Inc., Canada is acquired by Piramal Enterprises Ltd., part of the Life Sciences vertical, Bio-Orthopedics division
Minard International Inc. is acquired.
RxEliteinc, the U.S. based inhalation anaesthetic gas distribution business, is acquired
Nicholas Piramal India Limited renamed to Piramal Healthcare Limited.
Khandelwal Laboratories is acquired
Scientists from Piramal led the first exploration by an Indian pharmaceutical company to develop drug leads from geographies like Antarctica.
Piramal Healthcare listed as global leader by S&P Global Challengers.
Pfizer's Morpeth UK facility acquired
Piramal Glass acquires a part of The Glass Group (erstwhile Wheaton Glass) in USA.
Avecia Pharmaceutical is acquired
Nicholas forges alliance with scientists from Imperial College of the UK to carry out research in the field of rheumatoid arthritis.
Global Bulk Drugs is acquired.
Sarabhai Piramal is acquired
ICI Pharma is acquired.
Started collaborative research with Centre for Biochemical Technology in the field of gene technology.
Rhone Poulenc India Limited is acquired
Piramal Glass acquires Ceylon Company Ltd, Sri Lanka.
Acquired the research unit of Hoechst Marion Roussel (India) in Mumbai.
NPIL entered into an agreement with Reckitt & Colman for joint marketing of the latter's OTC products in India.
Entered into a product tie-up with F. Hoffman-La-Roche.
Boehringer Mannheim is acquired
The bulk drug division of Sumitra Pharmaceutical and Chemicals Ltd. Hyderabad transferred to NPIL.
A joint venture agreement was entered into with Satelec, France for dental care products
Piramal entered into a joint venture agreement with Allergan of U.S.A., the leading manufacturers of Ophthalmic products.
Set up a second formulation plant at Pithampur in Madhya Pradesh with state-of-the-art manufacturing facilities.
A new formulation plant at Pithampur in Madhya Pradesh is commissioned.
Gujarat Glass is merged with the group company, Nicholas Piramal India Ltd
Acquired Nicholas Laboratories.
Acquired Gujarat Glass
In the early 1980s a young Ajay Piramal takes the reins of the Piramal Group